Literature DB >> 2250501

Medication compliance and health education among outpatients with chronic mental disorders.

G R Kelly1, J E Scott, J Mamon.   

Abstract

Medication noncompliance occurs among as many as one-third to one-half of all medical and psychiatric outpatients. Noncompliance has serious consequences for individuals diagnosed with schizophrenia, often resulting in higher rates of relapse and rehospitalization, and poorer community adjustment. Health education interventions have been shown to be effective in promoting compliance among patients with chronic medical illness such as hypertension or diabetes, but there have been few randomized trials of this approach among patients with chronic psychiatric disorders. This paper presents the results of an application of health education among a group of male psychiatric outpatients. Two interventions were developed which used health education techniques to 1) engage families or significant others as active participants in the aftercare process, and 2) train patients to become effective health care consumers. A total of 418 individuals participated in a six-month trial over a four-year study. Both interventions significantly improved medication compliance among those who received them. The results show that comparatively brief interventions can significantly alter medication compliance behavior and improve the quality of life for patients with chronic psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2250501     DOI: 10.1097/00005650-199012000-00006

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  23 in total

1.  Family interventions for mental disorders: efficacy and effectiveness.

Authors:  Ian R H Falloon
Journal:  World Psychiatry       Date:  2003-02       Impact factor: 49.548

2.  Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA.

Authors:  Natalie C Edwards; Julie C Locklear; Marcia F T Rupnow; Ronald J Diamond
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 3.  Psychoeducation for schizophrenia.

Authors:  Jun Xia; Lars Bertil Merinder; Madhvi R Belgamwar
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

4.  Medication adherence in schizophrenia: exploring patients', carers' and professionals' views.

Authors:  Martijn J Kikkert; Aart H Schene; Maarten W J Koeter; Debbie Robson; Anja Born; Hedda Helm; Michela Nose; Claudia Goss; Graham Thornicroft; Richard J Gray
Journal:  Schizophr Bull       Date:  2006-08-03       Impact factor: 9.306

5.  Cost-effectiveness model of long-acting risperidone in schizophrenia in the US.

Authors:  Natalie C Edwards; Marcia F T Rupnow; Chris L Pashos; Marc F Botteman; Ronald J Diamond
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

6.  Randomised trial of personalised computer based information for patients with schizophrenia.

Authors:  R B Jones; J M Atkinson; D A Coia; L Paterson; A R Morton; K McKenna; N Craig; J Morrison; W H Gilmour
Journal:  BMJ       Date:  2001-04-07

Review 7.  Interventions to improve medication compliance in older patients living in the community: a systematic review of the literature.

Authors:  Monique van Eijken; Sui Tsang; Michel Wensing; Peter A G M de Smet; Richard P T M Grol
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

8.  Engagement processes in model programs for community reentry from prison for people with serious mental illness.

Authors:  Beth Angell; Elizabeth Matthews; Stacey Barrenger; Amy C Watson; Jeffrey Draine
Journal:  Int J Law Psychiatry       Date:  2014-03-18

9.  Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole.

Authors:  Izchak Kohen; Paula E Lester; Sum Lam
Journal:  Neuropsychiatr Dis Treat       Date:  2010-03-24       Impact factor: 2.570

10.  A community project to encourage compliance with mental health treatment aftercare.

Authors:  S Bostelman; M Callan; L C Rolincik; M Gantt; M Herink; J King; M K Massey; D Morehouse; T Sopata; J Turner
Journal:  Public Health Rep       Date:  1994 Mar-Apr       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.